Thrive

Agios Pharmaceuticals, based in Cambridge, MA, is a pioneering leader in cellular metabolism, dedicated to developing innovative therapies for patients with rare diseases, particularly focusing on hemolytic and acquired anemias. The company emphasizes collaboration with patient communities and healthcare professionals, ensuring that patient needs and insights are at the forefront of their therapeutic advancements. With a strong commitment to maintaining a supportive and flexible work environment, Agios encourages its team members to bring their authentic selves to work, thereby fostering creativity and driving scientific discoveries. Their mission is centered around creating impactful therapies that provide long-term, disease-modifying effects for patients who face unmet medical needs. Generated from the website

Voyager Therapeutics Inc., based in Cambridge, MA, is a biotechnology company focused on leveraging human genetics to develop transformative medicines for neurological diseases. Their robust pipeline includes genetic therapies targeting conditions such as Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and Parkinson's disease, utilizing the innovative TRACER AAV capsid discovery platform for optimal delivery across the blood-brain barrier. Dedicated to advancing neurogenetic medicines, Voyager Therapeutics prides itself on its talented workforce and collaborative environment. The company aims to modify the course of debilitating neurological disorders and ultimately find cures through its pioneering research and development efforts. Generated from the website